- Home
- FGL vs RADX Comparison
FGL vs RADX Comparison
Compare FGL & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- RADX
- Stock Information
- Founded
- FGL 2021
- RADX 2021
- Country
- FGL Malaysia
- RADX Australia
- Employees
- FGL N/A
- RADX N/A
- Industry
- FGL
- RADX
- Sector
- FGL
- RADX
- Exchange
- FGL NYSE
- RADX NYSE
- Market Cap
- FGL 25.4M
- RADX 32.5M
- IPO Year
- FGL 2024
- RADX N/A
- Fundamental
- Price
- FGL $0.85
- RADX $4.05
- Analyst Decision
- FGL
- RADX Strong Buy
- Analyst Count
- FGL 0
- RADX 2
- Target Price
- FGL N/A
- RADX $13.50
- AVG Volume (30 Days)
- FGL 1.2M
- RADX 22.6K
- Earning Date
- FGL 07-15-2025
- RADX 02-26-2025
- Dividend Yield
- FGL N/A
- RADX N/A
- EPS Growth
- FGL N/A
- RADX N/A
- EPS
- FGL N/A
- RADX N/A
- Revenue
- FGL $20,205,441.00
- RADX $204,609.00
- Revenue This Year
- FGL N/A
- RADX N/A
- Revenue Next Year
- FGL N/A
- RADX N/A
- P/E Ratio
- FGL N/A
- RADX N/A
- Revenue Growth
- FGL N/A
- RADX N/A
- 52 Week Low
- FGL $0.66
- RADX $3.50
- 52 Week High
- FGL $5.26
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- RADX N/A
- Support Level
- FGL N/A
- RADX N/A
- Resistance Level
- FGL N/A
- RADX N/A
- Average True Range (ATR)
- FGL 0.00
- RADX 0.00
- MACD
- FGL 0.00
- RADX 0.00
- Stochastic Oscillator
- FGL 0.00
- RADX 0.00
About FGL FOUNDER GROUP LTD
Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.